Funding for this research was provided by:
European Commission (ERC-834682 CELLPHASE_AD)
Fonds Wetenschappelijk Onderzoek
KU Leuven (Methusalem)
Medical Research Council (DRI)
Alzheimer’s Research UK (DRI)
Alzheimer Society (DRI)
Geneeskundige stichting Koningin Elisabet
opening the Future Leuven
Received: 29 May 2020
Accepted: 18 August 2020
First Online: 19 October 2020
: All animal experiments were conducted according to protocols approved by the local Animal Ethical Committee of the KU Leuven (governmental license LA1210579), which adheres to local governmental and EU guidelines. All procedures with human brain tissue were conducted according to protocols approved by the local Ethical Committee overseeing the use of human .samples (protocol number S61186).
: All authors read and approved the final manuscript.
: The authors report no competing interests. Bart de Strooper is, or has been, a consultant for pharmaceutical companies, including Jansen Pharmaceuticals and Eisai.